Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T16769 | Target Info | |||
Target Name | X-linked inhibitor of apoptosis protein (XIAP) | ||||
Synonyms |
hILP; hIAP3; hIAP-3; Xlinked IAP; X-linked IAP; RING-type E3 ubiquitin transferase XIAP; Inhibitor of apoptosis protein 3; ILP; IAPlike protein; IAP3; IAP-like protein; IAP-3; E3 ubiquitinprotein ligase XIAP; E3 ubiquitin-protein ligase XIAP; Baculoviral IAP repeatcontaining protein 4; Baculoviral IAP repeat-containing protein 4; BIRC4; API3
Click to Show/Hide
|
||||
Target Type | Clinical trial Target | ||||
Gene Name | XIAP | ||||
Biochemical Class | Acyltransferase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Cellular inhibitor of apoptosis 1 (BIRC2) | Clinical trial Target | ||||
UniProt ID | BIRC2_HUMAN | |||||
Gene Name | BIRC2 | |||||
Synonyms |
hIAP2; hIAP-2; TNFR2TRAFsignaling complex protein 2; TNFR2-TRAF-signaling complex protein 2; RNF48; RING-type E3 ubiquitin transferase BIRC2; RING finger protein 48; MIHB; Inhibitor of apoptosis protein 2; IAP2; IAP homolog B; CIAP1; C-IAP1; Baculoviral IAP repeatcontaining protein 2; Baculoviral IAP repeat-containing protein 2; API1
Click to Show/Hide
|
|||||
Representative Drug(s) | AT-406 | Drug Info | Ki = 1.9 nM | Click to Show More | [1] | |
2 | GDC-0152 | Drug Info | IC50 = 10.4 nM | [2] | ||
3 | Birinapant | Drug Info | IC50 = 50 nM | [3] | ||
Co-Target Name | Cellular inhibitor of apoptosis 2 (BIRC3) | Clinical trial Target | ||||
UniProt ID | BIRC3_HUMAN | |||||
Gene Name | BIRC3 | |||||
Synonyms |
hIAP1; hIAP-1; TNFR2TRAFsignaling complex protein 1; TNFR2-TRAF-signaling complex protein 1; RNF49; RING-type E3 ubiquitin transferase BIRC3; RING finger protein 49; MIHC; Inhibitor of apoptosis protein 1; IAP1; IAP homolog C; CIAP2; C-IAP2; Baculoviral IAP repeatcontaining protein3; Baculoviral IAP repeat-containing protein 3; Apoptosis inhibitor 2; API2
Click to Show/Hide
|
|||||
Representative Drug(s) | AT-406 | Drug Info | Ki = 5.1 nM | Click to Show More | [1] | |
2 | GDC-0152 | Drug Info | IC50 = 12.9 nM | [2] | ||
Co-Target Name | Melanoma inhibitor of apoptosis protein (ML-IAP) | Patented-recorded Target | ||||
UniProt ID | BIRC7_HUMAN | |||||
Gene Name | BIRC7 | |||||
Synonyms |
UNQ5800/PRO19607/PRO21344; RNF50; RING-type E3 ubiquitin transferase BIRC7; RING finger protein 50; MLIAP; Livin; Kidney inhibitor of apoptosis protein; KIAP; Baculoviral IAP repeat-containing protein 7
Click to Show/Hide
|
|||||
Representative Drug(s) | GDC-0152 | Drug Info | Ki < 50 nM | [4] | ||
Co-Target Name | Max-like protein X (MLX) | Co-Target | ||||
UniProt ID | MLX_HUMAN | |||||
Gene Name | MLX | |||||
Synonyms |
Class D basic helix-loop-helix protein 13; bHLHd13; Max-like bHLHZip protein; Protein BigMax; Transcription factor-like protein 4
Click to Show/Hide
|
|||||
Representative Drug(s) | GDC-0152 | Drug Info | Ki = 14 nM | [4] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment. J Med Chem. 2011 Apr 28;54(8):2714-26. | ||||
REF 2 | Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach. J Med Chem. 2018 Jul 26;61(14):6350-63. | ||||
REF 3 | Discovery of potent heterodimeric antagonists of inhibitor of apoptosis proteins (IAPs) with sustained antitumor activity. J Med Chem. 2015 Feb 12;58(3):1556-62. | ||||
REF 4 | Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152). J Med Chem. 2012 May 10;55(9):4101-13. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.